Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!

Latest Data & Signals Issued

Signal Type Signal Value Data
Score -3.028 20 days ( 17.39 % )
Last Price $1.33 0.758 %
High/ Low $1.28 - $1.40 4.29%
Chg 7 Days -2.21 % $1.36 $1.33
Chg 30 Days -23.12 % $1.73 $1.33
Chg 12 mos 114.55 % $0.620 $1.33
Trend - 3 mos -31.71 % Width: 147.61 %
Trend - 12 mos 99.85 % Width: 411.41 %
Pred. range - 3 mos $0.470 - $1.16 -64.70 % - -12.59 %
Pred. range - 12 mos $1.08 - $5.51 -19.00 % - 314.22 %
Short MA avg 3 mos Sell May 06, 2024 - 4 days
Long MA avg 3 mos Sell Mar 12, 2024 - 42 days
Short/Long MA avg 3 mos Sell Mar 14, 2024 - 40 days
Short MA avg 12 mos Buy May 07, 2024 - 3 days
Long MA avg 12 mos Buy Jan 03, 2024 - 89 days
Short/Long MA avg 12 mos Buy Jan 17, 2024 - 80 days
Pivot Short Sell Apr 22, 2024 - 14 days
Bollinger Buy Apr 15, 2024 - 19 days
MACD Buy No Dates Stored For This Signal

Signals Effectiveness

Backtesting is not only a way to check stock signal accuracy, but also a tool to continually improvement. Data can be used for self adjustment as each stock has an individual behavior.

Accuracy and return is not the same. A stock signal may provide low statistical accuracy, but the signals may prove high return in average.

Sharp market dips or fundamental changes (earning reports, news updates etc), may force a short term reaction and disturb the signals (Signals may jump quickly from buy to sell, just to return to buy).

Stock Score

Buy Signals
Sell Signals

Bollinger Bands

Buy Signals
Sell Signals

MACD

Buy Signals
Sell Signals

Moving Average (7d)

Buy Signals
Sell Signals
Click to get the best stock tips daily for free!

About Alaunos Therapeutics, Inc.

Alaunos Therapeutics. Alaunos Therapeutics, Inc., a clinical-stage oncology-focused cell therapy company, develops adoptive TCR engineered T-cell therapies. It develops TCR Library, which is in Phase I/II clinical trial for ten TCRs reactive to mutated KRAS, TP53, and EGFR from its TCR library for the treatment of non-small cell lung, colorectal, endometrial, pancreatic, ovarian, and bile duct cancers; hunTR, a human neoantigen T-cell receptor platform; and mbIL-15 to... TCRT Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT